miR-23b expression is downregulated in CRC, and several targets: TGFβR2, uPA, MAP3K1, PAK2, FZD7 [100] and PDE7A [101] have been identified, implicating a tumor suppressive role. The gene discussed is TGFBR2; the disease is neoplasm.